We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

Back to rankings

270 hedge funds and large institutions have $5.5B invested in CUBIST PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 109 increasing their positions, 86 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 86

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

2% less funds holding

Funds holding: 276 → 270 (-6)

15% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 41

29% less capital invested

Capital invested by funds: $7.7B → $5.5B (-$2.21B)

96% less call options, than puts

Call options by funds: $16.1M | Put options by funds: $446M

Holders
270
Holders Change
-6
Holders Change %
-2.17%
% of All Funds
7.76%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.23%
New
35
Increased
109
Reduced
86
Closed
41
Calls
$16.1M
Puts
$446M
Net Calls
-$430M
Net Calls Change
-$419M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$46.5M
2
PI
Putnam Investments
Massachusetts
+$42.3M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$41.7M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$36.5M
5
HM
HealthCor Management
New York
+$34M

Top Sellers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$576M
2
MC
Maverick Capital
Texas
-$127M
3
EAM
Eagle Asset Management
Florida
-$38.5M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$29.5M
5
CAM
Cormorant Asset Management
Massachusetts
-$21.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
EBIM
26
Eagle Boston Investment Management
Massachusetts
$40.4M -$1.25M -18,394 -3%
O
27
OppenheimerFunds
New York
$39.6M +$2.26M +33,180 +6%
TI
28
Turner Investments
Pennsylvania
$39M -$4.03M -59,314 -10%
Morgan Stanley
29
Morgan Stanley
New York
$36.1M -$2.25M -33,049 -6%
First Trust Advisors
30
First Trust Advisors
Illinois
$35.6M +$7.11M +104,606 +26%
AIMCA
31
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$33.8M +$6.78M +99,680 +26%
U
32
UBS
Switzerland
$27.6M +$4.09M +60,180 +18%
Point72 Asset Management
33
Point72 Asset Management
Connecticut
$27.5M +$26.8M +394,200 New
RIM
34
RS Investment Management
California
$27.3M -$7.77M -114,280 -23%
Geode Capital Management
35
Geode Capital Management
Massachusetts
$26.8M +$1.3M +19,058 +5%
AAM
36
AMI Asset Management
California
$25.4M +$3.53M +51,910 +17%
AAMU
37
Amundi Asset Management US
Massachusetts
$25.1M -$657K -9,661 -3%
Neuberger Berman Group
38
Neuberger Berman Group
New York
$24M +$8.13M +119,550 +53%
TCIM
39
TIAA CREF Investment Management
New York
$23.9M +$4.44M +65,241 +24%
SIMG
40
Stephens Investment Management Group
Texas
$22M +$4.27M +62,720 +25%
Goldman Sachs
41
Goldman Sachs
New York
$19.5M -$2.63M -38,627 -12%
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$19.4M +$136K +2,003 +0.7%
BG
43
BlackRock Group
United Kingdom
$19.4M +$454K +6,677 +2%
VOYA Investment Management
44
VOYA Investment Management
Georgia
$19.2M -$822K -12,087 -4%
BIM
45
BlackRock Investment Management
Delaware
$18.9M +$1.3M +19,123 +8%
Bank of America
46
Bank of America
North Carolina
$18.7M -$3.06M -44,936 -14%
TCM
47
Tekla Capital Management
Massachusetts
$18.4M +$2.52M +37,000 +16%
Fidelity International
48
Fidelity International
Bermuda
$18.2M -$11M -161,549 -38%
Allianz Asset Management
49
Allianz Asset Management
Germany
$17.7M +$958K +14,090 +6%
Barclays
50
Barclays
United Kingdom
$16.9M -$4.43M -65,140 -21%
1
2
3 4 5

CBST Hedge Fund Activity: Q2 2014 in Review

270 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q2 2014, worth a combined $5.5B — down 29% from $7.7B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of CBST and 35 opened new positions — a net loss of 6 holders — while 86 trimmed existing stakes and 109 added.

The largest buyer was Fidelity Investments, adding an estimated $46.5M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $576M.

  • 270 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q2 2014, down from 276 in Q1 2014.
  • Funds reported $5.5B of CUBIST PHARMACEUTICALS INC stock for Q2 2014, down 29% quarter-over-quarter.
  • 35 funds opened new CUBIST PHARMACEUTICALS INC positions in Q2 2014 and 41 closed out, a net change of -6 holders.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q2 2014 was Fidelity Investments, an estimated $46.5M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q2 2014 was BNP Paribas Financial Markets, an estimated $576M sold.

Based on aggregated 13F filings for Q2 2014.